Last viewed: AZN

Prices are updated after-hours

AZN Nasdaq 2021 - 01 - 29

Astrazeneca PLC

AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

(0.0% 1d) (4.4% 1m) (-6.7% 1y) (0.0% 2d) (0.0% 3d) (1.6% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 211,667,214,664
http://astrazeneca.com
Sec Filling | Patents | 70600 employees

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

cardiovascular respiratory urea renal metabolic

add to watch list Paper trade email alert is off

Press-releases

Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

| 0.0% | O: -0.77% H: 0.0% C: 0.0%
million series trials program

Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
NVS | $93.2 -1.28% 0.0% 1.6M

|

Health Technology

| 0.22% | O: -1.46% H: 0.0% C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M

|

Health Technology

| 0.0% | O: -1.63% H: 0.0% C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M

|

Health Technology

| 0.0% | O: -2.13% H: 0.0% C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

| 0.0% | O: -0.77% H: 0.0% C: 0.0%
set therapeutics market

FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | $135.94 -4.19% 770

|

Health Technology

| -0.23% | O: 1.47% H: 1.16% C: -1.27%
AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

| 1.64% | O: 3.34% H: 0.27% C: -0.62%
children approved treatment for

Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published: 2024-04-08 (Crawled : 18:00) - prnewswire.com
SNYNF | $92.966 -2.18% 630

|

Health Technology

| 0.3% | O: 2.24% H: 0.0% C: -0.8%
AZNCF | $135.94 -4.19% 770

|

Health Technology

| 2.04% | O: -3.43% H: 6.21% C: 6.21%
VTRS | $11.12 -1.77% -1.8% 6.8M

|

Health Technology

| -4.07% | O: -0.25% H: 1.1% C: -0.17%
NVS | $93.2 -1.28% 0.0% 1.6M

|

Health Technology

| -1.44% | O: -0.05% H: 0.43% C: -0.27%
BMY | $48.26 -0.52% 0.04% 12M

|

Health Technology

| -5.48% | O: -0.08% H: 0.04% C: -0.35%
BHC | $8.74 1.28% 0.11% 2.5M

|

Health Technology

| -17.1% | O: 0.38% H: 0.0% C: -7.27%
ABBV | $162.54 0.54% 0.0% 4.8M

|

Health Technology

| -3.72% | O: 0.77% H: 1.63% C: 0.35%
SNY | $45.81 -0.93% -0.94% 1.4M

|

Health Technology

| -0.12% | O: 0.84% H: 0.0% C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

| 1.9% | O: 0.18% H: 0.3% C: 0.19%
eczema dermatitis set therapeutics market

Genome Editing Market size is set to grow by USD 7.23 bn from 2024-2028,rapid technological advancements in genome editing boost the market- Technavio
Published: 2024-04-05 (Crawled : 22:00) - prnewswire.com
AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

| Email alert Add to watchlist
TMO | $554.55 -0.6% 0.0% 1M

|

Health Technology

| Email alert Add to watchlist
CRBU | $4.0 -1.72% -1.75% 1.3M

|

Health Technology

| Email alert Add to watchlist
AZNCF | $135.94 -4.19% 770

|

Health Technology

| Email alert Add to watchlist
set market

Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Published: 2024-04-02 (Crawled : 08:00) - biospace.com/
AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

| 1.14% | O: -1.18% H: 0.34% C: -0.22%
breast her2 license cancer application negative

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

| Email alert Add to watchlist
CKPT | $1.665 -3.2% -3.3% 510K

|

Health Technology

| Email alert Add to watchlist
FBIO | $1.79 -1.65% -1.68% 190K

|

Health Technology

| Email alert Add to watchlist
MBIO | $0.361 -3.73% -3.88% 360K

|

Health Technology

| Email alert Add to watchlist
AZNCF | $135.94 -4.19% 770

|

Health Technology

| Email alert Add to watchlist
DERM | $3.77 -6.22% -6.63% 120K

|

| Email alert Add to watchlist
biotech financial results

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

|

Health Technology

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | $92.966 -2.18% 630

|

Health Technology

| -6.75% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | $135.94 -4.19% 770

|

Health Technology

| 0.92% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | $93.6375 6.88% 82K

|

Health Technology

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $93.2 -1.28% 0.0% 1.6M

|

Health Technology

| -1.53% | O: 0.52% H: 0.0% C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M

|

Health Technology

| -5.79% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.26 -0.52% 0.04% 12M

|

Health Technology

| -8.9% | O: 0.26% H: 2.03% C: 1.57%
ABBV | $162.54 0.54% 0.0% 4.8M

|

Health Technology

| -10.36% | O: 0.36% H: 0.72% C: 0.61%
ABT | $109.21 0.29% 0.34% 7.3M

|

Health Technology

| -2.83% | O: 1.04% H: 0.0% C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M

|

Health Technology

| -5.73% | O: -0.96% H: 0.0% C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

| 0.69% | O: -0.12% H: 0.25% C: -0.63%
AMGN | $265.64 0.05% 0.05% 2M

|

Health Technology

| -7.26% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
AZNCF | $135.94 -4.19% 770

|

Health Technology

| 2.7% | O: 0.75% H: 0.04% C: -0.1%
AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

| 3.73% | O: -0.08% H: 0.33% C: -0.53%
ARTL | $1.4337 -3.74% 3K

|

Health Technology

| -5.68% | O: -4.61% H: 4.83% C: 3.84%
business update financial results

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business UpdateMajor achievements in 2023 lay the foundation for key upcoming milestones
Published: 2024-03-25 (Crawled : 16:00) - biospace.com/
AZNCF | $135.94 -4.19% 770

|

Health Technology

| 2.7% | O: 0.75% H: 0.04% C: -0.1%
AZN | $68.27 -0.67% -0.67% 3.8M

|

Health Technology

| 3.73% | O: -0.08% H: 0.33% C: -0.53%
ARTL | $1.4337 -3.74% 3K

|

Health Technology

| -5.68% | O: -4.61% H: 4.83% C: 3.84%
business lay key financial results foundation

See all

Last 15 days Sec forms

File Id

Form

Published Date

Transaction Date

Direction

Code

Amount Transacted

Owned Amount

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

58%

42%

Top 10 Gainers

WISA 4 | $6.06 246.29% 71.12% 200M

|

Electronic Technology

VIAO | $0.265 -13.96% 35.85% 960K

|

Electronic Technology

JAGX | $0.178 49.83% 33.26% 600M

|

Health Technology

SXTC | $1.68 43.59% 30.36% 34M

|

Health Technology

DYNT | $0.531 43.36% 30.24% 22M

|

Health Technology

KA | $0.4796 41.06% 29.11% 5.3M

|

PALI | $5.86 40.87% 29.01% 29M

|

CLNN | $0.319 -3.74% 28.75% 6.3M

|

BSGM | $1.52 38.18% 27.63% 3.3M

|

Health Technology

MCBC | $13.67 37.66% 27.36% 2.2M

|

Last 48 Hours Insiders Buying

KFS P 481 | $8.6 1.06% 0.0% 15K

|

| 20:30
AINC | $4.83 -1.43% 1.45% 98K

|

| 20:30
RVP P 3587 | $1.065 -1.39% 0.47% 49K

|

Health Technology

| 17:00
TPL P 12 | $586.93 0.52% 0.0% 50K

|

| 16:01
HNRA | $2.76 16.95% -1.81% 400K

|

| 15:02
TGEN | $0.67 39.71% 16K

|

| 14:30
RMCF | $3.6492 -7.2% 9.2K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar